SLP

Simulations Plus
NASDAQ

实时行情|Nasdaq Last Sale

33.89
-0.36
-1.05%
盘后: 33.89 0 0.00% 16:00 04/03 EDT
开盘
34.21
昨收
34.25
最高
35.54
最低
33.10
成交量
10.88万
成交额
--
52周最高
41.95
52周最低
19.74
市值
5.98亿
市盈率(TTM)
67.54
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测SLP价格均价为39.50,最高价位40.00,最低价为39.00。

EPS

SLP 新闻

更多
  • Simulations Plus Sets Date for 2nd Quarter 2020 Earnings Release and Conference Call
  • Business Wire · 1天前
  • Simulations Plus Acquires Lixoft, Expanding Modeling Software Offerings and Broadening Presence in Europe
  • Business Wire · 1天前
  • Simulations Plus Reports Purchase Of Lixoft For $16.5M In Cash, Stock
  • Benzinga · 1天前
  • Simulations Plus Looking To Restart Its Ascent
  • Seeking Alpha - Article · 4天前

所属板块

先进医疗设备和技术
-1.50%
医疗设备和用品
-1.17%

热门股票

代码
价格
涨跌幅

SLP 简况

Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.
展开

微牛提供Simulations Plus, Inc.(NASDAQ-SLP)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的SLP股票新闻,以帮助您做出投资决策。